Insulet Corporation (PODD) Misses Q4 EPS by 4c; Guides FY12 Revs
Tweet
Share
E-mailGet Alerts PODD Hot Sheet
Price: $147.48 -2.06%
Revenue Growth %: +18.1%
Financial Fact:
Other expense, net: -5.37M
Today's EPS Names:
VIVO, BIOX, PMCB, More
Revenue Growth %: +18.1%
Financial Fact:
Other expense, net: -5.37M
Today's EPS Names:
VIVO, BIOX, PMCB, More
Join SI Premium – FREE
Insulet Corporation (NASDAQ: PODD) reported Q4 EPS of ($0.30), $0.04 worse than the analyst estimate of ($0.26). Revenue for the quarter came in at $47.2 million versus the consensus estimate of $47.44 million.
Sees FY2012 revenue of $210-$225 million, versus the consensus of $218.4 million.
For earnings history and earnings-related data on Insulet Corporation (PODD) click here.
Sees FY2012 revenue of $210-$225 million, versus the consensus of $218.4 million.
For earnings history and earnings-related data on Insulet Corporation (PODD) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- EU proposes to curb Airbnb and short-term rentals amid housing shortage
- Concurrent Technologies (CNC:LN) PT Raised to GBP3.20 at Berenberg
- ICICI Bank (ICICIBC:IN) (IBN) PT Raised to INR2,000 at Goldman Sachs
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
